πŸ‡ΊπŸ‡Έ FDA
Patent

US 9302120

Spiro-oxindole MDM2 antagonists

granted A61KA61K31/407A61K45/06

Quick answer

US patent 9302120 (Spiro-oxindole MDM2 antagonists) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/407, A61K45/06, A61P, A61P17/00